RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 Protocols: The Essential Handbook for Regeneration and Health: BPC157 Peptides: Lyman, Dan: 9798309682713: Amazon.com: Books